Eden Research plc
EDNSF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $1,199 | $2,417 | $1,886 | $2,050 |
| % Growth | -50.4% | 28.1% | -8% | – |
| Cost of Goods Sold | $1,490 | $1,138 | $1,292 | $716 |
| Gross Profit | $155 | $1,278 | $594 | $1,333 |
| % Margin | 13% | 52.9% | 31.5% | 65.1% |
| R&D Expenses | $245 | $181 | $117 | $160 |
| G&A Expenses | $1,853 | $1,808 | $1,702 | $1,747 |
| SG&A Expenses | $1,971 | $1,933 | $1,782 | $1,865 |
| Sales & Mktg Exp. | $118 | $125 | $80 | -$142 |
| Other Operating Expenses | $223 | $16 | $30 | $0 |
| Operating Expenses | $2,439 | $2,131 | $1,928 | $2,087 |
| Operating Income | -$2,283 | -$852 | -$1,334 | -$665 |
| % Margin | -190.5% | -35.3% | -70.7% | -32.4% |
| Other Income/Exp. Net | -$4 | -$19 | $29 | -$62 |
| Pre-Tax Income | -$2,287 | -$871 | -$1,305 | -$727 |
| Tax Expense | -$442 | $129 | -$396 | $111 |
| Net Income | -$1,867 | -$990 | -$916 | -$607 |
| % Margin | -155.7% | -41% | -48.6% | -29.6% |
| EPS | -0.003 | -0.002 | -0.002 | -0.001 |
| % Growth | -31.6% | -11.8% | -30.8% | – |
| EPS Diluted | -0.003 | -0.002 | -0.002 | -0.001 |
| Weighted Avg Shares Out | 533,452 | 526,282 | 533,563 | 460,938 |
| Weighted Avg Shares Out Dil | 533,353 | 533,353 | 533,353 | 460,930 |
| Supplemental Information | – | – | – | – |
| Interest Income | $24 | $63 | $44 | $34 |
| Interest Expense | $11 | $0 | $6 | $8 |
| Depreciation & Amortization | $661 | $83 | $81 | $69 |
| EBITDA | -$1,588 | -$770 | -$1,219 | -$595 |
| % Margin | -132.5% | -31.8% | -64.6% | -29.1% |